Trial intelligence / Profile preview

Midazolam Versus Dexmedetomidine for Sedation in Mechanically Ventilated Critically Ill Patients

NCT01256866Phase 4Unknown

Sponsor
Hospital São Domingos
Start
Nov 2010
Primary completion
Oct 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of dexmedetomidine in critical illness (2 arms), sponsored by Hospital São Domingos. Primary endpoint: Incidence of delirium. Status: unknown.

02

Drugs

dexmedetomidine
03

Conditions

critical illness

Beyond the preview

Go deeper on NCT01256866.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01256866.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call